Baron Partners Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell Midcap Growth Index.

Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of ...

Savant Capital LLC lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 14.4% in the 4th ...

Shares of IDEXX Laboratories Inc. IDXX shed 1.38% to $457.35 Wednesday, on what proved to be an all-around poor trading ...

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

As of Thursday morning, IDEXX Laboratories shares are down by 0.49%, with a current price of $455.12. This implies that Erickson's 1,544 shares have a value of $597,944.

Piper Sandler raised the firm’s price target on Idexx Laboratories (IDXX) to $510 from $435 and keeps a Neutral rating on the shares. The firm ...

IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.